Search Results

Activin A Signaling Regulates IL13Rα2 Expression to Promote Breast Cancer Metastasis.

• Authors : Kalli, Maria; Mpekris, Fotios; Wong, Chen K.

Subjects: ACTIVIN; INTERLEUKIN-13; METASTATIC breast cancer

• Source: Frontiers in Oncology; 2/5/2019, pN.PAG-N.PAG, 12p

Record details

The potential markers of endocrine resistance among HR+ /HER2+ breast cancer patients.

• Authors : Chen, K.; Quan, J.; Yang, J.

• Source: Clinical & Translational Oncology; Apr2020, Vol. 22 Issue 4, p576-584, 9p

Record details

PDZ and LIM domain protein 1(PDLIM1)/CLP36 promotes breast cancer cell migration, invasion and metastasis through interaction with α-actinin.

• Authors : Liu, Z; Zhan, Y; Tu, Y

Subjects: BREAST cancer; CANCER cell migration; CANCER invasiveness

• Source: Oncogene; 3/5/2015, Vol. 34 Issue 10, p1300-1311, 12p, 2 Diagrams, 8 Graphs

Record details

Cumulative survival in early-onset unilateral and bilateral breast cancer: an analysis of 1907 Taiwanese women.

• Authors : Kuo, W. -H.; Yen, A. M. -F.; Lee, P. -H.

Subjects: BREAST cancer; CANCER in women; CANCER prognosisTAIWAN

• Source: British Journal of Cancer; 2/24/2009, Vol. 100 Issue 4, p563-570, 8p, 1 Diagram, 3 Charts, 2 Graphs

Record details

Ribosomal phosphoprotein P0 interacts with GCIP and overexpression of P0 is associated with cellular proliferation in breast and liver carcinoma cells.

• Authors : Chang, T.-W.; Chen, C.-C.; Chen, K.-Y.

Subjects: PHOSPHOPROTEINS; CELL proliferation; CYCLINS

• Source: Oncogene; 1/10/2008, Vol. 27 Issue 3, p332-338, 7p, 1 Color Photograph, 2 Black and White Photographs, 1 Graph

Record details

Estrogen receptor-positive mammary tumorigenesis in TGFα transgenic mice progresses with progesterone receptor loss.

• Authors : Rose-Hellekant, T. A.; Schroeder, M. D.; Brockman, J. L.

Subjects: ESTROGEN receptors; CARCINOGENESIS; TRANSGENIC mice

• Source: Oncogene; 8/9/2007, Vol. 26 Issue 36, p5238-5246, 9p, 1 Color Photograph, 2 Charts, 5 Graphs

Record details

Improving efficacy of TNBC immunotherapy: based on analysis and subtyping of immune microenvironment.

• Authors : Yalan Yang; Haifeng Li; Wei Yang

• Source: Frontiers in Immunology; 2024, p1-18, 18p

Record details

Research on therapeutic clinical trials including immunotherapy in triple-negative breast cancer: a bibliometric analysis.

• Authors : Qi Xu; Xiaoyu Feng; Siyuan Qin

Subjects: TRIPLE-negative breast cancer; BIBLIOMETRICS; BREAST cancer

• Source: Frontiers in Oncology; 2024, p1-13, 13p

Record details

Targeted therapy approaches for epithelial-mesenchymal transition in triple negative breast cancer.

• Authors : Haque, Mazharul; Shyanti, Ritis K.; Mishra, Manoj K.

Subjects: TRIPLE-negative breast cancer; EPIDERMAL growth factor receptors; IMMUNE checkpoint inhibitors

• Source: Frontiers in Oncology; 2024, p01-19, 19p

Record details

Prognostic Impact of Acute and Chronic Inflammatory Interleukin Signatures in the Tumor Microenvironment of Early Breast Cancer.

• Authors : Heimes, Anne-Sophie; Shehaj, Ina; Almstedt, Katrin

Subjects: BIOMARKERS; BRCA genes; IMMUNE checkpoint proteins

• Source: International Journal of Molecular Sciences; Oct2024, Vol. 25 Issue 20, p11114, 17p

Record details